FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012034012> ?p ?o ?g. }

• W2012034012 endingPage "212" @default.
• W2012034012 startingPage "205" @default.
• W2012034012 abstract "Aims Palliative radiotherapy for bone metastases remains an important treatment in patients with metastatic malignancy. Previous studies have indicated a reluctance to adopt single-fraction treatment despite considerable evidence. This study aims to describe the factors determining the use of palliative radiotherapy in patients with bone metastases and assess whether fractionation patterns have changed over time with emerging evidence. Materials and methods A retrospective review of radiotherapy databases at Liverpool/Macarthur Cancer Therapy Centre and the Royal Brisbane and Women's Hospital was conducted for the period 1997–2009. Patients receiving palliative radiotherapy for bony metastases were identified and treatment sites were grouped into ‘spine’, ‘limb’, ‘multiple’ or ‘other’. Treatment courses were divided into single- or multiple-fraction treatments. The effects of socioeconomic and geographical factors on radiotherapy utilisation and fractionation were assessed. Results In total, 5683 patients were identified in the cohort; they received a total of 8211 bone treatments. The overall proportion of single-fraction radiotherapy was 29%, with significant variation over the study period (P < 0.001). Age under 70 years and spine or multiple treatment sites were all associated with lower usage of single-fraction radiotherapy on multivariate analysis. Prostate and lung primary sites were associated with higher usage of single-fraction treatment. The proportion of single-fraction treatment remained low (35%), even for patients who survived less than 22 days from their last treatment. Socioeconomic and geographical factors had little effect on the number of fractions used. Conclusions The rate of single-fraction radiotherapy for bone metastases has remained low in two large Australian institutions, despite considerable evidence that single-fraction treatment provides equivalent pain relief to fractionated therapy. This trend towards fractionated treatment was largely maintained, even in patients with limited life expectancy. Further measures to increase the rate of single-fraction therapy are needed." @default.
• W2012034012 created "2016-06-24" @default.
• W2012034012 creator A5009111193 @default.
• W2012034012 creator A5012984487 @default.
• W2012034012 creator A5019969764 @default.
• W2012034012 creator A5054044407 @default.
• W2012034012 creator A5057127797 @default.
• W2012034012 creator A5077856644 @default.
• W2012034012 date "2015-04-01" @default.
• W2012034012 modified "2023-09-24" @default.
• W2012034012 title "Factors Affecting the Use of Single-Fraction Radiotherapy for the Palliation of Bone Metastases in Australia" @default.
• W2012034012 cites W1608460440 @default.
• W2012034012 cites W1967635737 @default.
• W2012034012 cites W1989098069 @default.
• W2012034012 cites W1990718568 @default.
• W2012034012 cites W1992625706 @default.
• W2012034012 cites W1997101148 @default.
• W2012034012 cites W2000016107 @default.
• W2012034012 cites W2019582591 @default.
• W2012034012 cites W2022098162 @default.
• W2012034012 cites W2023141374 @default.
• W2012034012 cites W2023987851 @default.
• W2012034012 cites W2025110241 @default.
• W2012034012 cites W2025442147 @default.
• W2012034012 cites W2047842438 @default.
• W2012034012 cites W2053787128 @default.
• W2012034012 cites W2054254305 @default.
• W2012034012 cites W2060117317 @default.
• W2012034012 cites W2078574113 @default.
• W2012034012 cites W2088724004 @default.
• W2012034012 cites W2089009335 @default.
• W2012034012 cites W2095742548 @default.
• W2012034012 cites W2108145085 @default.
• W2012034012 cites W2113235727 @default.
• W2012034012 cites W2121439814 @default.
• W2012034012 cites W2136392842 @default.
• W2012034012 cites W2139879375 @default.
• W2012034012 cites W2148458500 @default.
• W2012034012 cites W2166870452 @default.
• W2012034012 cites W2169719471 @default.
• W2012034012 cites W4237557603 @default.
• W2012034012 doi "https://doi.org/10.1016/j.clon.2014.11.027" @default.
• W2012034012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25533480" @default.
• W2012034012 hasPublicationYear "2015" @default.
• W2012034012 type Work @default.
• W2012034012 sameAs 2012034012 @default.
• W2012034012 citedByCount "20" @default.
• W2012034012 countsByYear W20120340122015 @default.
• W2012034012 countsByYear W20120340122017 @default.
• W2012034012 countsByYear W20120340122018 @default.
• W2012034012 countsByYear W20120340122019 @default.
• W2012034012 countsByYear W20120340122020 @default.
• W2012034012 countsByYear W20120340122021 @default.
• W2012034012 countsByYear W20120340122022 @default.
• W2012034012 crossrefType "journal-article" @default.
• W2012034012 hasAuthorship W2012034012A5009111193 @default.
• W2012034012 hasAuthorship W2012034012A5012984487 @default.
• W2012034012 hasAuthorship W2012034012A5019969764 @default.
• W2012034012 hasAuthorship W2012034012A5054044407 @default.
• W2012034012 hasAuthorship W2012034012A5057127797 @default.
• W2012034012 hasAuthorship W2012034012A5077856644 @default.
• W2012034012 hasConcept C121608353 @default.
• W2012034012 hasConcept C126322002 @default.
• W2012034012 hasConcept C141071460 @default.
• W2012034012 hasConcept C159110408 @default.
• W2012034012 hasConcept C167135981 @default.
• W2012034012 hasConcept C2779399171 @default.
• W2012034012 hasConcept C2994186709 @default.
• W2012034012 hasConcept C38180746 @default.
• W2012034012 hasConcept C509974204 @default.
• W2012034012 hasConcept C71924100 @default.
• W2012034012 hasConceptScore W2012034012C121608353 @default.
• W2012034012 hasConceptScore W2012034012C126322002 @default.
• W2012034012 hasConceptScore W2012034012C141071460 @default.
• W2012034012 hasConceptScore W2012034012C159110408 @default.
• W2012034012 hasConceptScore W2012034012C167135981 @default.
• W2012034012 hasConceptScore W2012034012C2779399171 @default.
• W2012034012 hasConceptScore W2012034012C2994186709 @default.
• W2012034012 hasConceptScore W2012034012C38180746 @default.
• W2012034012 hasConceptScore W2012034012C509974204 @default.
• W2012034012 hasConceptScore W2012034012C71924100 @default.
• W2012034012 hasFunder F4320314607 @default.
• W2012034012 hasIssue "4" @default.
• W2012034012 hasLocation W20120340121 @default.
• W2012034012 hasLocation W20120340122 @default.
• W2012034012 hasOpenAccess W2012034012 @default.
• W2012034012 hasPrimaryLocation W20120340121 @default.
• W2012034012 hasRelatedWork W2003938723 @default.
• W2012034012 hasRelatedWork W2030729277 @default.
• W2012034012 hasRelatedWork W2047967234 @default.
• W2012034012 hasRelatedWork W2089462794 @default.
• W2012034012 hasRelatedWork W2118496982 @default.
• W2012034012 hasRelatedWork W2364998975 @default.
• W2012034012 hasRelatedWork W2369162477 @default.
• W2012034012 hasRelatedWork W2439875401 @default.
• W2012034012 hasRelatedWork W4238867864 @default.
• W2012034012 hasRelatedWork W2525756941 @default.
• W2012034012 hasVolume "27" @default.

• next